Joint hypermobility syndromes

Current Opinion in Rheumatology

Volumn 8, Issue 5, 1996, Pages 459-466

  Raff, Michael L ^a   Byers, Peter H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHONDROPLASIA; ARTICLE; CERVICAL MYELOPATHY; CONNECTIVE TISSUE DISEASE; EHLERS DANLOS SYNDROME; JOINT HYPERMOBILITY; MARFAN SYNDROME; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL;

EID: 0029835903     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199609000-00012     Document Type: Article

References (82)

1. Carter C, Wilkinson J: Persistent Joint laxity and congenital dislocation of the hip. J Bone Joint Surg Br 1964, 40:40-45.
2. Beighton P, Solomon L, Soskolne C: Articular mobility in an African population. Ann Rheum Dis 1973, 32:413-418.
3. Cheng J, Chan P: Joint laxity in children. J Pediatr Orthop 1991, 11:752-756.
4. Wordsworth P, Ogilvie D, Smith R, Sykes B: Joint mobility with particular reference to racial variation and inherited connective tissue disorders. Br J Rheumatol 1987, 26:9-12.
5. Silman A, Haskard O, Day S: Distribution of joint mobility in a normal population: results of the use of fixed torque measuring devices. Ann Rheum Dis 1986, 45:27-30.
6. Jessee E, Owen D, Sagar K: The benign hypermobile joint syndrome. Arthritis Rheum 1980, 23:1053-1056.
7. Dubs L, Gschwend N: General joint laxity. Arch Orthop Trauma Surg 1988, 107:65-72.
8. Biro F, Gewanter H, Baum J: The hypermobility syndrome. Pediatrics 1983, 72:701-706.
9. Wynne-Davies R: Acetabular dysplasia and familial joint laxity: two etiological factors in congenital dislocation of the hip. J Bone Joint Surg Br 1970, 52:704-716.
10. Beighton P, De Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall J, Hollister D, Horton W, McKusick V, et al.: International nosology of heritable disorders of connective tissue. Am J Med Genet 1988, 29:581-594.
11. Steinmann B, Royce P, Superti-Furga A: The Ehlers-Danlos syndrome. In Connective Tissue and Its Heritable Disorders. Edited by Royce P, Steinmann B. New York: Wiley-Liss and Sons; 1993:351-407.
12. Beighton P: The Ehlers-Danlos syndromes. In McKusick's Heritable Disorders of Connective Tissue, edn 5. Edited by Beighton P. St. Louis: Mosby; 1993:189-251.
13. Byers P, Holbrook K: Ehlers-Danlos syndrome. In Principles and Practice of Medical Genetics, edn 2. Edited by Emery A, Rimoin D. New York: Churchill Livingstone; 1990:1065-1081.
14. Beighton P: Articular manifestation of the Ehlers-Danlos syndrome. Semin Arthritis Rheum 1971,1:246-261.
15. Loughlin J, Irven C, Hardwick L, Butcher S, Walsh S, Wordsworth P, Sykes B: Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II). Hum Mol Genet 1995, 4:1649-1651. The authors hone in on the molecular etiology of EDS type II.
16. Burrows N, Nicholls A, Yates J, Gatward G, Sarathachandra P, Richards A, Pope F: The gene encoding collagen α1 (V) (COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol 1996, 106:1273-1276. The authors demonstrate linkage to the COL5A1 gene and describe the mutation in the individual discussed by Nicholls et al. (Am J Hum Genet 1994, 55S:A233).
17. Burrows N, Nicholls A, Yates J, Gatward G, Sarathachandra P, Richards A, Pope F: The gene encoding collagen α1 (V) (COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol 1996, 106:1273-1276. The authors demonstrate linkage to the COL5A1 gene and describe the mutation in the individual discussed by Nicholls et al. (Am J Hum Genet 1994, 55S:A233).
18. Nicholls A, McCarron S, Narcisi P, Pope F: Molecular abnormalities of type V collagen in Ehlers Danlos syndrome. Am J Hum Genet 1994, 55S:A233.
19. Toriello H, Glover T, Takahara K, Byers P, Miller D, Higgins J, Greenspan D: A translocation Interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nature Genet 1996,13:361-365. The authors describe a truncation mutation in one COL5A1 allele due to a translocation between the X chromosome and chromosome 9.
20. Greenspan D, Northrup H, Au K, McAllister K, Francomano C, Wenstrup R, Marchuk D, Kwiatkowski D: COL5A1: fine genetic mapping and exclusion as candidate gene in families with nall-patella syndrome, tuberous sclerosis 1, hereditary hemorrhaglc telanglectasla, and Ehlers-Danlos syndrome type II. Genomics 1995, 25:737-739.
21. Pope F, Martin G, Lichtenstein J, Penttinen R, Gereon B, Rowe D, McKusick V: Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci U S A 1975, 72:1314-1316.
22. Tsipouras P, Byers P, Schwarte R, Chu M, Weil D, Pepe G, Cassidy S, Ramirez F: Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen. Hum Genet 1986, 74:41-46.
23. Byers P: Ehlers-Danlos syndrome type IV: a genetic disorder in many guises. J Invest Dermatol 1995, 105:311-313.
24. Wenstrup R, Murad S, Pinnell S: Ehlers-Danlos syndrome type VI: clinical manifestation of collagen lysyl hydroxylase deficiency. J Pediatr 1989, 115:405-409.
25. Pinnell S, Krane S, Kenzora J, Glimcher M: A heritable disorder of connective tissue: hydroxylysine-deficient collagen disease. N Engl J Med 1972, 286:1013-1020.
26. Hyland J, Ala-Kokko L, Royce P, Steinmann B, Kivirikko K, Myllyla R: A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. Nature Genet 1992, 2:228-231.
27. Hautala T, Heikkinen J, Kivirikko K, Myllyla R: A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings. Genomics 1993, 15:399-404.
28. Ha V, Marshall M, Elsas L, Pinnell S, Yeowell H: A patient with Ehlers-Danlos type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. J Clin Invest 1994, 93:1716-1721.
29. Pasquali M, Dembure P, Still M, Elsas L: Urinary pyridinium cross-links: a noninvasive diagnostic test for Ehlers-Danlos syndrome type VI. N Engl J Med 1994, 331:132-133.
30. Steinmann B, Eyre D, Shao P: Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI. Am J Hum Genet 1995, 57:1505-1508.
31. Pasquali M, Still M, Dembure P, Elsas L: Pyridinium cross-links in heritable disorders of collagen. Am J Hum Genet 1995, 57:1508-1510.
32. Weil D, D'Alessio M, Ramirez F, de Wet W, Cole W, Chan D, Batemen J: A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII. EMBO J 1989, 8:1705-1710.
33. D'Alessio M, Ramirez F, Blumberg B, Wirtz M, Rao V, Godfrey M, Hollister D: Characterization of a COL1A1 splicing defect in a case of EhlersDanlos syndrome type VII: further evidence of molecular heterogeneity. Am J Hum Genet 1991, 49:400-406.
34. Weil D, Bernard M, Combates N, Wirtz M, Hollister D, Steinmann B, Ramirez F: Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. J Biol Chem 1988, 263:8561-8564.
35. Vasan N, Kuivaniemi H, Vogel B, Minor R, Wooton J, Tromp G, Weksberg R, Prockop D: A mutation in the proα2(I) gene (COL1A2) for type I collagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype. Am J Hum Genet 1991, 48:305-317.
36. Chiodo A, Hickey A, Cole W: A base substitution at the splice acceptor site of Intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. J Biol Chem 1992, 267:6361-6369.
37. Watson R, Wallis G, Holmes D, Viljoen D, Byers P, Kadler K: Ehlers-Danlos syndrome type VIIB. J Biol Chem 1992, 267:9093-9100.
38. Nicholls A, Oliver J, Renouf D, McPheat J, Palan A, Pope F: Ehlers-Danlos syndrome type VII: a singe base pair change that causes exon skipping in the type I collagen α2(I) chain. Hum Genet 1991, 87:193-198.
39. Lanaers A, Ansay M, Nusgens B, Lapiere C: Collagen made of extended α-chains, procollagen, in genetically defective dermatosparaxic calves. Eur J Biochem 1971, 23:533-543.
40. Smith L, Wertelecki W, Milstone L, Petty E, Seashore M, Braverman I, Jenkins T, Byers P: Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet 1992, 51:235-244.
41. Wertelecki W, Smith L, Byers P: Initial observations of human dermatosparaxls: Ehlers-Danlos syndrome type VIIC. J Pediatr 1992, 121:558-564.
42. Nusgens B, Verellen-Dumoulin C, Hermanns L, De Paepe A, Nuytinck L, Pierard G, Lapiere C: Evidence for a relationship between Ehlers-Danlos type VIIC in humans and bovine dermatosparaxls. Nature Genet 1992, 1:214-217.
43. Petty E, Seashore M, Braverman I, Spiesel S, Smith L, Milstone L: Dermatosparaxis in children: a case report and review of the newly recognized phenotype. Arch Dermatol 1993, 129:1310-1315.
44. Reardon W, Winter R, Smith L, Lake B, Rossiter M, Baraitser M: The natural history of human dermatosparaxis (Ehlers-Danlos syndrome type VIIC). Clin Dysmorphol 1995, 4:1-11.
45. Elsas L, Miller R, Pinnell S: Inherited human collagen lysyl hydroxylase deficiency: ascorbic acid response. J Pediatr 1978, 92:378-384.
46. Pyeritz R: The Marfan syndrome. In Connective Tissue and Its Heritable Disorders. Edited by Royce P, Steinmann B. New York: Wiley-Liss and Sons; 1993:437-468.
47. De Paepe A, Dervereux R, Dietz H, Hennekam R, Pyeritz R: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996, 62:417-426.
48. Morse R, Rockenmacher S, Pyeritz R, Sanders S, Bieber F, Lin A, MacLeod P, Hall B, Graham J: Diagnosis and management of infantile Marfan syndrome. Pediatrics 1990, 86:888-895.
49. Grahame R, Pyeritz R: The Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br J Rheumatol 1995, 34:126-131.
50. Sponseller P, Hobbs W, Riley L, Pyeritz R: The thoracolumbar spine in Marfan syndrome. J Bone Joint Surg Am 1995, 77:867-876.
51. Duncan R, Esses S: Marfan syndrome with back pain secondary to pedicular attenuation. Spine 1995, 20:1197-1198.
52. Dietz H, Cutting G, Pyeritz R, Maslen C, Sakai L, Corson G, Puffenburger E, Hamosh A, Nanthakumar E, Curristin S, et al.: Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337-339.
53. Lee B, Godfrey M, Vitale E, Hori H, Mattei M, Sarfarazi M, Tsipouras P, Ramirez F, Hollister D: Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 1991, 352:330-334.
54. Tsipouras P, Del Mastro R, Sarfarazi M, Lee B, Vitale E, Child A, Godfrey M, Devereaux R, Hewitt D, Steinmann B, et al.: Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. N Engl J Med 1992, 326:905-909.
55. Dietz H, Pyeritz R: Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 1995, 4:1799-1809.
56. Nijbroek G, Sood S, McIntosh I, Francomano C, Bull E, Pereira L, Ramirez F, Pyeritz R, Dietz H: Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995, 57:8-21.
57. Byers P: Osteogenesis imperfecta. In Connective Tissue and Its Heritable Disorders. Edited by Royce P, Steinmann B. New York: Wiley-Liss and Sons; 1993:317-350.
58. Byers P: Disorders of collagen biosynthesis and structure. In The Metabolic and Molecular Bases of Inherited Disease, edn 7. Edited by Scriver C, Beaudet A, Sly W, Valle D. New York: McGraw-Hill; 1995:4029-4077.
59. Sillence D, Senn A, Danks D: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979, 16:101-116.
60. Rowe D, Shapiro J, Poirier M, Schlesinger S: Diminshed type I collagen synthesis and reduced alpha 1 (I) collagen messenger RNA in culture fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J Clin Invest 1985, 76:604-611.
61. Willing M, Pruchno C, Atkinson M, Byers P: Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet 1992, 51:508-515.
62. Stover M, Primorac O, Liu S, McKinstry M, Rowe D: Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta. J Clin Invest 1993, 92:1994-2002.
63. Willing M, Deschenes S, Scott D, Byers P, Slayton R, Pitts S, Arikat H, Roberts E: Osteogenesis Imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet: 1994, 55:638-657.
64. Larsen L, Schottstaedt E, Boat F: Multiple congenital dislocations associated with characteristic facial abnormality. J Pediatr 1950, 23:574-581.
65. Vujic M, Hallstensson K, Wahlstrom J, Lundberg A, Langmaack C, Martinsson: Localization of a gene for autosomal dominant Larsen syndrome to chromosome region 3p21.1-14.1 in the proximity of, but distinct from, the COL7A1 locus. Am J Hum Genet 1995, 57:1104-1113.
66. Stickler G, Belau P, Farrell F, Jones J, Pugh D, Steinberg A, Ward L: Hereditary progressive arthro-ophthalmopathy. Mayo Clin Proc 1965, 40:433-455.
67. Korkko J, Ritvaniemi P, Haataja L, Kaariainen H, Kivirikko K, Prockop D, Ala-Kokko L: Mutation in type II procollagen (COL2A1) that substitutes aspartate for glycine α1-67 and that causes cataracts and retinal detachment: evidence for molecular heterogeneity in the Wagner syndrome and the Stickler syndrome (arthro-ophthalmopathy). Am J Hum Genet 1993, 53:55-61.
68. Vikkula M, Mariman E, Lui V, Zhidkova N, Tiller G, Goldring M, van Beersum S, de Wall Malefijt, van den Hoogen F, Ropers H, et al.: Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995, 80:431-437.
69. Epstein C: Down syndrome (trisomy 21). In The Metabolic and Molecular Bases of Inherited Disease, edn 7. Edited by Scriver C, Beaudet A, Sly W, Valle D. New York: McGraw-Hill; 1995:749-794.
70. Smith G, Berg J: Down's Anomaly. Edinburgh: Churchill Livingstone; 1976.
71. Neufeld E, Muenzer J: The mucopolysaccharidoses. In The Metabolic and Molecular Bases of Inherited Disease, edn 7. Edited by Scriver C, Beaudet A, Sly W, Valle D. New York: McGraw-Hill; 1995:2465-2494.
72. Wraith J: The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child 1995, 72:263-267.
73. Crockard H, Stevens J: Craniovertebral junction anomalies in Inherited disorders: part of the syndrome or caused by the disorder? Eur J Pediatr 1995, 154:504-512.
74. Morton R, Ali Khan M, Murray-Leslie C, Elliot S: Atlantoaxial instability in Down's syndrome: a five year follow up study. Arch Dis Child 1995, 72:115-118.
75. Pauli R, Horton V, Glinski L, Reiser C: Prospective assessment of risks for cervicomedullary-Junction compression in infants with achondroplasia. Am J Hum Genet 1995, 56:732-744.
76. Rimoin D: Cervicomedullary junction compression in infants with achondroplasia: when to perform neurosurgical decompression. Am J Hum Genet 1995, 56:824-827.
77. American Academy of Pediatrics, Committee on Sports Medicine: Atlantoaxial instability in Down syndrome: subject review. Pediatrics 1995, 96:151-154.
78. Gorlin R, Cohen M, Levin L: Syndromes of the Head and Neck, edn 3. New York: Oxford University Press; 1990:171-175.
79. Shiang R, Thompson L, Zhu Y, Church D, Fielder T, Bocian M, Winokur S, Wasmuth J: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994, 78:335-342.
80. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozel J, Maroteaux P, Le Merrer M, Munnich A: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371:252-254.
81. Bellus G, Hefferon T, Ortiz de Luna R, Hecht J, Horton W, Machado M, Kaitila I, McIntosh I, Francomano C: Achondroplasia is defined by recurrent G38OR mutations of FGFR3. Am J Hum Genet 1995, 56:368-373.
82. Hecht J, Francomano C, Horton W, Annegers J: Mortality in achondrodysplasia. Am J Hum Genet 1987, 41:454-464.